港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

劑泰科技-P

17.850

+1.86011.63%

成交量：1,570.90萬

成交額：2.66億

市值：211.17億

市盈率：-32.81

高：18.000

開：16.300

低：15.800

收：15.990

52周最高：29.980

52周最低：9.460

股本：11.83億

香港流通股本：10.83億

量比：2.51

換手率：1.45%

股息：- -

股息率：- -

每股收益(LYR):-0.544

淨資產收益率：--

總資產收益率：-20.01%

市淨率：5.99

市盈率(LYR):-32.81

市銷率: 70.03

資料載入中...

總覽公司新聞資訊公告

異動解讀 | 劑泰科技-P盤中大跌6.56%，IPO後持續回調新股熱度加速消退

異動解讀｜劑泰科技-P盤中下跌6.56%，IPO後持續回調新股熱度加速消退

劑泰科技－Ｐ(07666)股價顯著下跌11.466%，現價港幣$17.76

阿斯达克财经

異動解讀 | 新股熱度消退疊加獲利了結壓力，劑泰科技-P盤中大跌8.23%

異動解讀｜劑泰科技-P盤中下跌6.73%，IPO後持續回調新股熱度加速消退

異動解讀 | 劑泰科技-P盤中大跌5.48%，IPO後持續回調新股熱度消退

異動解讀 | 劑泰科技-P盤中大漲5.53%，與沙礫生物達成免疫靶向LNP技術合作

港股劑泰科技-P午前升逾4%

每日经济新闻

劑泰科技(07666)OpenCGT平台累計合作額超60億最新聯手沙礫生物達成免疫靶向遞送技術合作

異動解讀 | 劑泰科技-P盤中大跌7.1%，新股熱度消退疊加基本面擔憂

異動解讀 | 劑泰科技-P盤中大跌5.55%，IPO暴漲後遭遇獲利回吐壓力

劑泰科技－Ｐ(07666)股價顯著上升14.286%，現價港幣$27.2

阿斯达克财经

異動解讀 | 劑泰科技上市次日盤中大漲5.04%，AI藥物遞送第一股受熱捧

劑泰科技-P（7666.HK）上市首日收升逾120%，「製藥界SpaceX」成全球AI藥物遞送第一股

《新股》劑泰科技－Ｐ(07666.HK)首日開報28.68元高上市價173.1%

阿斯达克财经

異動解讀 | 劑泰科技-P盤中暴漲179.05%，IPO首日獲超6900倍超額認購引爆市場

劑泰科技-P首掛上市早盤上漲175.05%

劑泰科技-P香港首秀：開盤價定為每股28.68港元，較發行價飆升173%

《股市簡訊》中國醫藥納米材料平台劑泰科技香港首秀盤初一度漲186%

港股開盤 | 恒指高開0.08%，科指低開0.3%！劑泰科技-P首掛升逾173%、英派藥業-B首掛升逾76%

老虎资讯综合

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/07666/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07666","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"劑泰科技-P","latestPrice":17.85,"timestamp":1790755707007,"preClose":15.99,"halted":0,"volume":15709000,"delay":0,"changeRate":0.11632270168855542,"floatShares":1083000000,"shares":1183000000,"eps":-0.544063057183209,"marketStatus":"未開盤","change":1.86,"latestTime":"09-30 16:08:27","open":16.3,"high":18,"low":15.8,"amount":265977370,"amplitude":0.137586,"askPrice":17.85,"askSize":31500,"bidPrice":17.79,"bidSize":12000,"shortable":3,"etf":0,"ttmEps":-0.40181737151824237,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":15.99,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":2.510154709540251,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07666\",,,,,undefined,":{"symbol":"07666","floatShares":1083000000,"roa":"-20.01%","roe":"--","lyrEps":-0.544072,"volumeRatio":2.510154709540251,"shares":1183000000,"dividePrice":0,"high":18,"amplitude":0.137586,"preClose":15.99,"low":15.8,"week52Low":9.46,"pbRate":"5.99","psRate":"70.03","week52High":29.98,"institutionHeld":0,"latestPrice":17.85,"committee":-0.448276,"eps":-0.5440715949877597,"divideRate":0,"volume":15709000,"delay":0,"ttmEps":-0.40182367710752614,"open":16.3,"prevYearClose":10.5,"prevWeekClose":15.61,"prevMonthClose":17.85,"prevQuarterClose":17.85,"fiveDayClose":17.38,"twentyDayClose":12.3,"sixtyDayClose":13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07666\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"07666","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07666\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07666\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1789056000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07666\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07666","date":"2026-09-30","current":-44.43112,"percent":0.061856,"low":-64.32629,"twenty":-44.144401,"median":-36.419402,"eighty":-30.601435,"high":-25.115126,"avg":-37.409019,"sd":8.278369,"marketCap":21111156622},"quantilePoints":[{"date":"2026-05-15","current":-55.2918,"twenty":-62.155958,"median":-58.000435,"eighty":-43.892829,"marketCap":25009550545},{"date":"2026-05-22","current":-43.108917,"twenty":-60.122045,"median":-51.319082,"eighty":-42.587932,"marketCap":19454433788},{"date":"2026-05-29","current":-37.615042,"twenty":-57.955137,"median":-43.960548,"eighty":-41.311685,"marketCap":17034154703},{"date":"2026-06-05","current":-35.730788,"twenty":-53.702713,"median":-41.754744,"eighty":-37.805412,"marketCap":16204344731},{"date":"2026-06-12","current":-33.542538,"twenty":-49.179944,"median":-39.902739,"eighty":-33.466041,"marketCap":15201657681},{"date":"2026-06-18","current":-36.557324,"twenty":-45.569099,"median":-38.090968,"eighty":-33.980188,"marketCap":16607724578},{"date":"2026-06-26","current":-33.269555,"twenty":-43.790222,"median":-37.525599,"eighty":-33.862793,"marketCap":15040305742},{"date":"2026-07-03","current":-35.486471,"twenty":-43.108917,"median":-37.328817,"eighty":-34.391053,"marketCap":16054517930},{"date":"2026-07-10","current":-31.831683,"twenty":-41.806456,"median":-36.56437,"eighty":-33.415043,"marketCap":14383372848},{"date":"2026-07-17","current":-25.695281,"twenty":-41.703031,"median":-36.419402,"eighty":-32.652478,"marketCap":11651915023},{"date":"2026-07-24","current":-28.586248,"twenty":-41.050787,"median":-35.730788,"eighty":-30.94587,"marketCap":12965780812},{"date":"2026-07-31","current":-26.182193,"twenty":-40.132349,"median":-35.165287,"eighty":-28.502242,"marketCap":11897940371},{"date":"2026-08-07","current":-28.884867,"twenty":-39.287405,"median":-34.015343,"eighty":-27.992619,"marketCap":13151600092},{"date":"2026-08-14","current":-31.416679,"twenty":-38.648807,"median":-33.542538,"eighty":-28.093751,"marketCap":14322470963},{"date":"2026-08-21","current":-36.861025,"twenty":-38.587758,"median":-33.478791,"eighty":-28.154822,"marketCap":16841617384},{"date":"2026-08-28","current":-39.81123,"twenty":-38.587758,"median":-34.218497,"eighty":-28.502242,"marketCap":16415846158},{"date":"2026-09-04","current":-39.623229,"twenty":-38.587758,"median":-34.599368,"eighty":-28.723646,"marketCap":16344884287},{"date":"2026-09-11","current":-44.150996,"twenty":-39.829532,"median":-35.165287,"eighty":-28.859493,"marketCap":18237200847},{"date":"2026-09-18","current":-49.755181,"twenty":-41.181236,"median":-35.601303,"eighty":-28.956099,"marketCap":20578942590},{"date":"2026-09-25","current":-44.721922,"twenty":-43.518123,"median":-35.74716,"eighty":-30.09223,"marketCap":18461913438},{"date":"2026-09-30","current":-51.044188,"twenty":-44.144401,"median":-36.419402,"eighty":-30.601435,"marketCap":21111156622}],"updateTime":1790863977105},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07666\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141511499","title":"異動解讀 | 劑泰科技-P盤中大跌6.56%，IPO後持續回調新股熱度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1141511499","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141511499?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 14:46","pubTimestamp":1779346009,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大跌6.56%，引发了市场关注。消息面上，该股自上市以来持续面临回调压力。作为全球AI药物递送第一股，公司目前仍处于商业化早期阶段，过去三年累计亏损较大且营收波动，其长期业绩增长前景尚需时间验证，这影响了投资者的短期信心。此外，部分国际配售股份未设置禁售期，导致上市后持续面临获利了结压力。随着新股上市初期的市场热度加速消退，股价的承压回落态势得以延续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154081201","title":"異動解讀｜劑泰科技-P盤中下跌6.56%，IPO後持續回調新股熱度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1154081201","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154081201?lang=zh_tw&edition=fundamental","pubTime":"2026-05-21 14:45","pubTimestamp":1779345928,"startTime":"0","endTime":"0","summary":"5月21日，剂泰科技-P盘中下跌6.56%，报16.82港元，成交额9141.32万港元。该股自5月13日上市首日大涨173%后已连续多个交易日回调，较首日高点回撤显著。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。公司尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。随着新股上市初期市场热度加速消退，股价承压回落态势延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636972308","title":"劑泰科技－Ｐ(07666)股價顯著下跌11.466%，現價港幣$17.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2636972308","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636972308?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 11:58","pubTimestamp":1779249480,"startTime":"0","endTime":"0","summary":"[下跌股]剂泰科技－Ｐ(07666) 股价在上午11:58比前收市价显著下跌11.466%，现股价为港币$17.76。至目前为止，今日最高价为$19.7，而最低价为$17.76。总成交量为690.573万股，总成交金额为港币$1.283亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2605202398/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2605202398/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130824096","title":"異動解讀 | 新股熱度消退疊加獲利了結壓力，劑泰科技-P盤中大跌8.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130824096","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130824096?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 09:43","pubTimestamp":1779241389,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大跌8.23%，引起了市场的广泛关注。消息面上，剂泰科技作为全球AI药物递送第一股于近期登陆港交所，上市首日曾大幅上涨，但随后市场热度加速消退，股价进入连续回调阶段。公司目前尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证，这给股价带来基本面压力。此外，部分国际配售股份未设置禁售期，导致上市后存在持续的获利了结压力，进一步加剧了股价的下跌。综合来看，新股上市初期的炒作热情退潮、公司自身的盈利挑战以及股东套现压力，共同导致了剂泰科技-P此次盘中大幅下挫。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141184724","title":"異動解讀｜劑泰科技-P盤中下跌6.73%，IPO後持續回調新股熱度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1141184724","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141184724?lang=zh_tw&edition=fundamental","pubTime":"2026-05-20 09:40","pubTimestamp":1779241257,"startTime":"0","endTime":"0","summary":"5月20日，剂泰科技-P盘中下跌6.73%，报18.9港元，成交额1506.71万港元。该股自5月13日上市首日大涨173%后已连续多日回调，较首日高点回撤明显。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。公司尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后存在持续的获利了结压力。随着新股上市初期市场热度加速消退，股价承压回落态势延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188442804","title":"異動解讀 | 劑泰科技-P盤中大跌5.48%，IPO後持續回調新股熱度消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1188442804","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188442804?lang=zh_tw&edition=fundamental","pubTime":"2026-05-19 09:54","pubTimestamp":1779155647,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中股价大跌5.48%，引发了市场的关注。消息面上，剂泰科技作为全球AI药物递送第一股，近期刚刚完成首次公开募股并上市。然而，公司在上市首日经历大幅上涨后，股价正进入持续回调阶段。这主要由于公司尚处于商业化的早期阶段，过去三年累计亏损约15亿元人民币，营收表现波动，其未来的业绩增长潜力仍需时间来验证。此外，部分国际配售的股份在上市后并未设置禁售期，这导致了潜在的获利了结压力。随着新股上市初期的市场热度逐渐消退，股价面临的下行压力也随之显现。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141700930","title":"異動解讀 | 劑泰科技-P盤中大漲5.53%，與沙礫生物達成免疫靶向LNP技術合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1141700930","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141700930?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 13:26","pubTimestamp":1779082017,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大涨5.53%，引起了市场的广泛关注。消息面上，剂泰科技宣布与肿瘤免疫细胞治疗企业沙砾生物正式签署全面技术合作战略协议，双方将围绕免疫靶向脂质纳米颗粒（LNP）递送技术展开合作，共同推进新一代体内免疫治疗产品的研发与转化，此举提振了市场对公司技术实力和未来增长前景的信心。此次合作依托剂泰科技自研的全球首个AI纳米递送平台NanoForge，是其OpenCGT项目赋能合作伙伴的又一重要里程碑。截至目前，剂泰科技OpenCGT项目已与多家细胞与基因治疗（CGT）领域企业达成技术合作，累计合作总额已超过60亿元人民币，展现了其平台技术的商业吸引力和行业影响力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636049383","title":"港股劑泰科技-P午前升逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636049383","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636049383?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 11:56","pubTimestamp":1779076619,"startTime":"0","endTime":"0","summary":"5月18日，剂泰科技-P(07666.HK)午前涨超4%，截至发稿，涨3.5%，报22.46港元，成交额6295.67万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605183740200963.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740200963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VXUS","07666","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636459100","title":"劑泰科技(07666)OpenCGT平台累計合作額超60億 最新聯手沙礫生物達成免疫靶向遞送技術合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2636459100","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636459100?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 10:59","pubTimestamp":1779073183,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技今日宣布，与肿瘤免疫细胞治疗企业沙砾生物正式签署全面技术合作战略协议，双方将围绕免疫靶向脂质纳米颗粒递送技术展开合作，共同推进新一代体内免疫治疗产品的研发与转化。此次合作依托剂泰科技自研的全球首个AI纳米递送平台NanoForge，是该平台赋能OpenCGT项目的又一重要里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1125108383","title":"異動解讀 | 劑泰科技-P盤中大跌7.1%，新股熱度消退疊加基本面擔憂","url":"https://stock-news.laohu8.com/highlight/detail?id=1125108383","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125108383?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 09:40","pubTimestamp":1779068418,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中股价大幅下挫，跌幅达到7.10%，市场表现引人关注。消息面上，剂泰科技作为全球AI药物递送第一股，于近期登陆港交所，上市首日曾录得显著涨幅。然而，新股热度正逐渐消退，股价自高点持续回调。公司目前仍处于商业化早期阶段，过去三年累计亏损约15亿元，营收表现波动，未来业绩增长前景尚需时间验证。此外，有市场分析指出，该股部分国际配售股份未设置禁售期，上市后存在一定的获利了结压力，这也是导致股价承压回落的重要因素之一。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157572291","title":"異動解讀 | 劑泰科技-P盤中大跌5.55%，IPO暴漲後遭遇獲利回吐壓力","url":"https://stock-news.laohu8.com/highlight/detail?id=1157572291","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157572291?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 10:02","pubTimestamp":1778810573,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大跌5.55%，引起了市场的广泛关注。消息面上，该股近期刚刚完成IPO，上市首日一度暴涨超过175%，暗盘交易价格最高触及44港元。然而，在经历了短期的大幅上涨后，股价开始持续回落，当前价格较暗盘高点已下跌超过45%，显示出明显的获利盘回吐压力。此外，市场对于其短期抛售压力也存在担忧。剂泰科技的IPO获得了超过6900倍的超额认购，并引入了18名基石投资者，但部分国际配售份额不受禁售期限制，这可能为市场带来额外的卖压。公司目前仍处于持续亏损状态，营收规模较小，其估值很大程度上依赖于AI药物递送这一概念的未来预期。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635476322","title":"劑泰科技－Ｐ(07666)股價顯著上升14.286%，現價港幣$27.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2635476322","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635476322?lang=zh_tw&edition=fundamental","pubTime":"2026-05-14 09:50","pubTimestamp":1778723400,"startTime":"0","endTime":"0","summary":"[上升股]剂泰科技－Ｐ(07666) 股价在上午09:50比前收市价显著上升14.286%，现股价为港币$27.2。至目前为止，今日最高价为$27.2，而最低价为$24.04。总成交量为488.81万股，总成交金额为港币$1.261亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2605142208/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2605142208/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147331990","title":"異動解讀 | 劑泰科技上市次日盤中大漲5.04%，AI藥物遞送第一股受熱捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1147331990","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147331990?lang=zh_tw&edition=fundamental","pubTime":"2026-05-14 09:39","pubTimestamp":1778722773,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大涨5.04%，延续了其上市首日的强劲表现。消息面上，剂泰科技于昨日正式在港交所挂牌上市，成为“全球AI药物递送第一股”及“港股AI大分子生物制药第一股”。剂泰科技的核心竞争力源于其自主研发的全球首个AI驱动纳米递送平台NanoForge，并基于此开发了多条产品管线。其中，核心产品MTS-004是中国首款完成III期临床的AI赋能制剂新药。这些积极的上市因素和公司基本面增强了市场信心，推动了股价的上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635856117","title":"劑泰科技-P（7666.HK）上市首日收升逾120%，「製藥界SpaceX」成全球AI藥物遞送第一股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635856117","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635856117?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 18:47","pubTimestamp":1778669227,"startTime":"0","endTime":"0","summary":"技术硬核 + 国家队加持","market":"us","thumbnail":"https://img3.gelonghui.com/24523-e88387b5-6c68-4c66-a045-ba7fdf93d4e5.jpg?guru_height=718&guru_width=1280&guru_size=85166","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/24523-e88387b5-6c68-4c66-a045-ba7fdf93d4e5.jpg?guru_height=718&guru_width=1280&guru_size=85166"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4752452","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["DXYZ","AIPO","07666","CHAT","01477","IPOS","AGIX","BK1191","BK1574","UFO","ARTY","XOVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227263","title":"《新股》劑泰科技－Ｐ(07666.HK)首日開報28.68元 高上市價173.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227263","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635227263?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 09:44","pubTimestamp":1778636640,"startTime":"0","endTime":"0","summary":"剂泰科技－Ｐ(07666.HK) 暗盘昨日收29.4元。高上市价180.0%。今日首日挂牌，开报28.68元，较上市价10.5元，高173.1%，开市时段成交4,863.17万股。(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142910475_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142910475_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1524207/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1524207/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161453310","title":"異動解讀 | 劑泰科技-P盤中暴漲179.05%，IPO首日獲超6900倍超額認購引爆市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1161453310","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161453310?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 09:36","pubTimestamp":1778636189,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中股价大涨179.05%，引起了市场的广泛关注。此次剧烈波动发生在该股于港交所主板的首个交易日。消息面上，股价飙升的主要原因在于其首次公开募股获得了市场的狂热追捧。根据配发结果，剂泰科技-P的香港公开发售部分获得了约6910.96倍的超额认购，锁定认购资金超过7300亿港元，成为2026年迄今港股医疗健康板块IPO的“冻资王”。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227610","title":"劑泰科技-P首掛上市 早盤上漲175.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227610","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635227610?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 09:36","pubTimestamp":1778636160,"startTime":"0","endTime":"0","summary":"　　剂泰科技-P首挂上市，公告显示，每股定价10.5港元，共发行2.01亿股股份，每手500股，所得款项净额约为19.93亿港元。截至发稿，股价上涨175.05%，现报28.88港元，成交额13.90亿港元。　　招股书显示，剂泰科技是一家AI纳米材料创新企业，致力于有效载荷在不同生命体中的递送与应用。　　管线方面，剂泰科技已布局超过10款产品，覆盖中枢神经、肿瘤、免疫、代谢等方向。其中，MTS-004为公司进展较快的候选产品。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2026-05-13/doc-inhxteir7736326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07666","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106879812","title":"劑泰科技-P香港首秀：開盤價定為每股28.68港元，較發行價飆升173%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106879812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106879812?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 09:21","pubTimestamp":1778635294,"startTime":"0","endTime":"0","summary":"备受瞩目的生物科技股剂泰科技-P（METIS TECHBIO-P）今日在香港交易所闪亮登场。其开盘价定于每股28.68港元，与10.50港元的发行价相比，实现了高达173%的惊人涨幅，为市场注入了一剂强心针。\n这一显著溢价充分反映了投资者对该公司所处赛道及其技术前景的浓厚兴趣与强烈信心。首日交易的表现，无疑将成为观察近期新股市场情绪与资金流向的关键风向标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227672","title":"《股市簡訊》中國醫藥納米材料平台劑泰科技香港首秀盤初一度漲186%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227672","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635227672?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 09:20","pubTimestamp":1778635251,"startTime":"0","endTime":"0","summary":"《股市简讯》中国医药纳米材料平台剂泰科技香港首秀盘初一度涨186%* 中国医药纳米材料解决方案提供商--剂泰科技7666.HK周三香港首日挂牌高开173%后，盘扩一度大涨幅至186%，触及29.98港元。* 该公司此前以招股价每股10.5港元发售约2.01亿股H股，集资21.1亿港元，香港公开发售和国际配售分别获约6,910倍及33倍超额认购。* 另一家同日挂牌、专注于抗癌疗法的中国生物技术公司--英派药业7630.HK高开77%后亦一度扩大升幅至82%，触及36.5港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL4T41Q013:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100453375","title":"港股開盤 | 恒指高開0.08%，科指低開0.3%！劑泰科技-P首掛升逾173%、英派藥業-B首掛升逾76%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100453375","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100453375?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 09:20","pubTimestamp":1778635230,"startTime":"0","endTime":"0","summary":"5月13日，港股开盘，恒指开涨0.08%，科指开跌0.3%。京东涨超3%，Q1营收同比小幅增长，调整后EBITDA远超预期，外卖业务亏损环比大幅收窄；泡泡玛特涨近4%，Q1收入预增75％至80％，欧美市场增长放缓，中国线上渠道预增150%；剂泰科技-P首挂涨超173%，公开发售阶段获6910.96倍认购，一手中签率0.14%；英派药业-B首挂涨超76%，公开发售阶段获2282.4倍认购，一手中签率1.5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07300","03088","03419","09067","07666","BK4588","02837","09088","09115","03423","02833","07226","03033","07500","82800","07630","03067","03417","BK4585","03037","03032","VXUS","HSI","03115","83115","02800","07200","513600","07552"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":8,"totalSize":172,"code":"91000000","status":"200"}]}}